Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer ...
You’ve probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss ...
An expert explains how the new program, which launches July 1, will work and who is eligible ...
Whether they’re using weekly shots or daily pills, more Americans than ever are turning to anti-obesity drugs to lose weight and boost health. About 1 in 8 U.S. adults say they are taking a GLP-1 drug ...
Most people have an opinion about GLP-1 medications. Fewer have accurate information. Dr. Jessica Duncan, a board-certified obesity medicine physician and the chief medical officer at Ivim Health, ...
GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting. Subscribe to ...
The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies. The orforglipron pill, called ...
This is read by an automated voice. Please report any issues or inconsistencies here. Whether they’re using weekly shots or daily pills, more Americans than ever are turning to anti-obesity drugs to ...